ConductScience.org, home

Library / Genes

KITLG: KIT ligand

1 protein, 168 patents, 0 drugs, 0 trials, 10,345 NIH grants and 21,064 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolKITLGHGNC
NameKIT ligandHGNC
NCBI Gene ID4254NCBI Gene
HGNC IDHGNC:6343HGNC
EnsemblENSG00000049130NCBI Gene
AliasesDCUA, DFNA69, FPH2, FPHH, KL-1, Kitl, MGF, SCF, SF, SHEP7, SLF, WS2FNCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
P21583Kit ligand2736Ensembl, GeneID, HGNCUniProt

Patents 168

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
JP 2026086743 A2026-05-26204P21583Espacenet
JP 2026043914 A2026-03-121P21583Espacenet
EP 4705273 A22026-03-11251P21583Espacenet
JP 2026508389 A2026-03-1071P21583Espacenet
EP 4650780 A22025-11-1919498P21583Espacenet
JP 2025169942 A2025-11-141114P21583Espacenet
WO 2025219552 A12025-10-238P21583Espacenet
JP 2025147176 A2025-10-0616776P21583Espacenet
US 12409237 B12025-09-0913P21583Espacenet
JP 2025529142 A2025-09-042308P21583Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 10345

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P30CA008748Cancer Center Support Grant1202,025NIH's project files
P30CA016672Cancer Center Support Grant872,025NIH's project files
P30CA021765Cancer Center Support Grant (CCSG)522,025NIH's project files
P30CA016058Cancer Center Support Grant372,025NIH's project files
R01AG011085Ubiquitin‐mediated proteolysis and cell cycle control352,025NIH's project files
P01CA108671Myeloproliferative Neoplasms-Research Consortium322,025NIH's project files
P30CA015704Cancer Center Support Grant312,025NIH's project files
ZIAAI000249The Pathogenesis, Diagnosis, and Treatment of Systemic Mast Cell Disorders302,025NIH's project files
P30CA016087Cancer Center Support Grant292,025NIH's project files
U54DK106846Hematopoietic stem and progenitor cell regulation for enhanced clinical efficacy292,025NIH's project files

Papers 21064

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42808596PubTator, text miningPubMed
42795184PubTator, text miningPubMed
42785104PubTator, text miningPubMed
42781308PubTator, text miningPubMed
42779827PubTator, text miningPubMed
42774987PubTator, text miningPubMed
42767567PubTator, text miningPubMed
42760543PubTator, text miningPubMed
42754254PubTator, text miningPubMed
42752598PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license